Skip to main content
logo
Y-Biologics, Inc. (KOSDAQ:338840)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,630.00
-550.00 (-6.72%)
At close: Oct 8, 2026

Y-Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
117,248347,578113,678230,299--
Market Cap Growth
-44.26%205.76%-50.64%---
Enterprise Value
95,227324,452102,035230,749--
Last Close Price
7630.0022900.007690.0015600.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
36.98119.3219.7366.19--
PB Ratio
6.8213.075.798.86--
P/TBV Ratio
7.0213.336.279.94--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
30.04111.3817.7166.33--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.960.560.040.110.250.21
Net Debt / Equity Ratio
-1.28-1.11-0.58-0.69-0.40-0.39
Net Debt / EBITDA Ratio
1.964.021.782.310.510.73
Net Debt / FCF Ratio
2.044.301.632.310.720.66
Asset Turnover
0.090.080.220.120.120.11
Quick Ratio
23.1735.9310.587.391.602.91
Current Ratio
23.8136.1610.737.481.703.20
Return on Equity (ROE)
-297.87%-181.79%-28.23%-90.84%-77.73%-54.50%
Return on Assets (ROA)
-23.92%-14.95%-20.30%-21.27%-34.84%-24.67%
Return on Capital Employed (ROCE)
-27.20%-17.00%-41.10%-37.00%-90.60%-54.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-42.60%-12.09%-5.67%-9.06%--
FCF Yield
-9.23%-1.98%-6.16%-3.39%--
Buyback Yield / Dilution
-2.33%-0.80%-18.01%-1.87%-1.01%-21.93%